Estradiol effects on the dopamine transporter - Protein levels, subcellular location, and function

Journal of Molecular Signaling

Volumn 1, Issue , 2006, Pages

  Watson, Cheryl S ^a   Alyea, Rebecca A ^a   Hawkins, Bridget E ^a   Thomas, Mary L ^a   Cunningham, Kathryn A ^a   Jakubas, Adrian A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250866740     PISSN: None     EISSN: 17502187     Source Type: Journal    
DOI: 10.1186/1750-2187-1-5     Document Type: Article

References (78)

1. Williams CL Estrogen effects on cognition across the lifespan Horm Behav 1998 34 80-84 10.1006/hbeh.1998.1480 9799619
2. Greenspan FS Gardner DG Appendix: Normal Hormone Reference Ranges Basic and Clinical Endocrinology New York, Lange Medical Books, McGraw Hill Greenspan FS and Gardner DG 7th 2004 Appendix 925-926
3. Halbreich U Kahn LS Role of estrogen in the aetiology and treatment of mood disorders CNS Drugs 2001 15 797-817 10.2165/ 00023210-200115100-00005 11602005
4. Staley JK Sanacora G Tamagnan G Maciejewski PK Malison RT Berman RM Vythilingam M Kugaya A Baldwin RM Seibyl JP Charney D Innis RB Sex differences in diencephalon serotonin transporter availability in major depression Biol Psychiatry 2006 59 40-47 10.1016/j.biopsych.2005.06.012 16139815
5. Walf AA Frye CA A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior Neuropsychopharmacology 2006 31 1097-1111 16554740
6. Prior JC Ovarian aging and the perimenopausal transition: The paradox of endogenous ovarian hyperstimulation Endocrine 2005 26 297-300 10.1385/ ENDO:26:3:297 16034185
7. Steiner M Dunn E Born L Hormones and mood: From menarche to menopause and beyond J Affect Disord 2003 74 67-83 10.1016/S0165-0327(02)00432-9 12646300
8. Yonkers KA Brown C Pearlstein TB Foegh M Sampson-Landers C Rapkin A Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder Obstet Gynecol 2005 106 492-501 16135578
9. Almeida OP Barclay L Sex hormones and their impact on dementia and depression: A clinical perspective Expert Opin Pharmacother 2001 2 527-535 10.1517/14656566.2.4.527 11336603
10. Stein D Hanukoglu A Blank S Elizur A Cyclic psychosis associated with the menstrual cycle Br J Psychiatry 1993 163 824-828 8306131
11. Oinonen KA Mazmanian D Does body fat protect against negative moods in women? Med Hypotheses 2001 57 387-388 10.1054/mehy.2001.1365 11516233
12. Taylor M Psychological consequences of surgical menopause J Reprod Med 2001 46 317-324 11304879
13. Soares CN Poitras JR Prouty J Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause Drugs Aging 2003 20 85-100 10.2165/00002512-200320020-00001 12534310
14. Rodie J [Use of estrogens in the treatment of mental disorders] Actas Esp Psiquiatr 2003 31 199-204 12838443
15. Compton J van AT Murphy D Mood, cognition and Alzheimer's disease Best Pract Res Clin Obstet Gynaecol 2002 16 357-370 10.1053/beog.2002.0285 12099667
16. Dluzen DE Mickley KR Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system Pharmacol Biochem Behav 2005 80 27-33 10.1016/j.pbb.2004.10.007 15652377
17. Foltynie T Lewis SG Goldberg TE Blackwell AD Kolachana BS Weinberger DR Robbins TW Barker RA The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease J Neurol 2005 252 833-838 10.1007/s00415-005-0756-5 15772739
18. Benedetti MD Maraganore DM Bower JH McDonnell SK Peterson BJ Ahlskog JE Schaid DJ Rocca WA Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study Mov Disord 2001 16 830-837 10.1002/mds.1170 11746612
19. Quinn PO Treating adolescent girls and women with ADHD: Gender-specific issues J Clin Psychol 2005 61 579-587 10.1002/jclp.20121 15723425
20. Kurlan R The pathogenesis of Tourette's syndrome. A possible role for hormonal and excitatory neurotransmitter influences in brain development Arch Neurol 1992 49 874-876 1355964
21. Luine VN Jacome LF MacLusky NJ Rapid enhancement of visual and place memory by estrogens in rats Endocr 2003 144 2836-2844 10.1210/ en.2003-0004
22. Shively CA Bethea CL Cognition, mood disorders, and sex hormones ILAR J 2004 45 189-199 15111738
23. Bender CM Sereika SM Berga SL Vogel VG Brufsky AM Paraska KK Ryan CM Cognitive impairment associated with adjuvant therapy in breast cancer Psychooncology 2006 15 422-430 10.1002/pon.964 16097037
24. Joffe H Hall JE Gruber S Sarmiento IA Cohen LS Yurgelun-Todd D Martin KA Estrogen therapy selectively enhances prefrontal cognitive processes: A randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women Menopause 2006 13 411-422 10.1097/01.gme.0000189618.48774.7b 16735938
25. Elman I Karlsgodt KH Gastfriend DR Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence Am J Drug Alcohol Abuse 2001 27 193-202 10.1081/ADA-100103705 11417935
26. Jackson LR Robinson TE Becker JB Sex differences and hormonal influences on acquisition of cocaine self-administration in rats Neuropsychopharmacology 2006 31 129-138 15920500
27. Sell SL Scalzitti JM Thomas ML Cunningham KA Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats J Pharmacol Exp Ther 2000 293 879-886 10869388
28. Watson CS Gametchu B Proteins of multiple classes participate in nongenomic steroid actions Exp Biol Med 2003 228 1272-1281
29. Watson CS Norfleet AM Pappas TC Gametchu B Rapid actions of estrogens in GH3/B6 pituitiary tumor cells via a plasma membrane version of estrogen receptor-" Steroids 1999 64 5-13 10.1016/S0039-128X(98)00107-X 10323667
30. Bannon MJ The dopamine transporter: Role in neurotoxicity and human disease Toxicol Appl Pharmacol 2005 204 355-360 10.1016/ j.taap.2004.08.013 15845424
31. MacLusky NJ Chalmers-Redman R Kay G Ju W Nethrapalli IS Tatton WG Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated PC12 cells and axotomized rat facial motoneurons Neuroscience 2003 118 741-754 10.1016/S0306-4522(02)00940-5 12710981
32. Gelinas S Bureau G Valastro B Massicotte G Cicchetti F Chiasson K Gagne B Blanchet J Martinoli MG Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress Neurotox Res 2004 6 141-148 15325966
33. Nilsen J Mor G Naftolin F Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells Menopause 1998 5 211-216 10.1097/ 00042192-199805040-00005 9872486
34. Pappas TC Gametchu B Watson CS Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding FASEB J 1995 9 404-410 7896011
35. Campbell CH Watson CS A comparison of membrane vs. intracellular estrogen receptor-" in GH3/B6 pituitary tumor cells using a quantitative plate immunoassay Steroids 2001 66 727-736 10.1016/ S0039-128X(01)00106-4 11522334
36. Razandi M Pedram A Greene GL Levin ER Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ER" and ERß expressed in chinese hamster ovary cells Mol Endocrinol 1999 13 307-319 10.1210/me.13.2.307 9973260
37. Revankar CM Cimino DF Sklar LA Arterburn JB Prossnitz ER A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 2005 307 1625-1630 10.1126/science.1106943 15705806
38. Filardo EJ Quinn JA Frackelton AR Bland KI Estrogen action via the G protein-coupled receptor, GPR30: Stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis Mol Endocrinol 2002 16 70-84 10.1210/ me.16.1.70 11773440
39. Thomas P Pang Y Filardo EJ Dong J Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocr 2005 146 624-632 10.1210/en.2004-1064
40. Sohrabji F Greene LA Miranda RC Toran-Allerand CD Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells J Neurobiol 1994 25 974-988 10.1002/neu.480250807 7525871
41. Bulayeva NN Gametchu B Watson CS Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways Steroids 2004 69 181-192 1201430 15072920 10.1016/ j.steroids.2003.12.003
42. Ciliax BJ Heilman C Demchyshyn LL Pristupa ZB Ince E Hersch SM Niznik HB Levey AI The dopamine transporter: Immunochemical characterization and localization in brain J Neurosci 1995 15 1714-1723 7534339
43. Lee E Mun GH Oh CS Chung YH Cha CL Lee YS Shin DH A subcellular distribution of estrogen receptor-alpha is changed during artificially induced senescence of PC12 pheochromocytoma cells Neurosci Lett 2004 372 80-84 10.1016/j.neulet.2004.09.017 15531092
44. Pappas TC Gametchu B Yannariello-Brown J Collins TJ Watson CS Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin Endocrine 1994 2 813-822
45. Norfleet AM Thomas ML Gametchu B Watson CS Estrogen receptor-a detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary cells by enzyme-linked immunocytochemistry Endocr 1999 140 3805-3814 10.1210/ en.140.8.3805
46. Campbell CH Bulayeva N Brown DB Gametchu B Watson CS Regulation of the membrane estrogen receptor-a: Role of cell density, serum, cell passage number, and estradiol FASEB J 2002 16 1917-1927 1266276 12468456 10.1096/ fj.02-0182com
47. Zivadinovic D Watson CS Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells Breast Cancer Res 2005 7 R130-R144 1064105 15642162 10.1186/bcr959
48. Koldzic-Zivanovic N Seitz PK Watson CS Cunningham KA Thomas ML Intracellular signaling involved in estrogen regulation of serotonin reuptake Mol Cell Endocrinol 2004 226 33-42 10.1016/j.mce.2004.07.017 15489003
49. Bulayeva NN Wozniak A Lash LL Watson CS Mechanisms of membrane estrogen receptor-{alpha}-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line Am J Physiol Endocrinol Metab 2005 288 E388-E397 1610112 15494610 10.1152/ajpendo.00349.2004
50. Holton KL Loder MK Melikian HE Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization Nat Neurosci 2005 8 881-888 15924135
51. Grigoriadis S Kennedy SH Role of estrogen in the treatment of depression Am J Ther 2002 9 503-509 10.1097/00045391-200211000-00008 12424508
52. Bloch M Schmidt PJ Danaceau M Murphy J Nieman L Rubinow DR Effects of gonadal steroids in women with a history of postpartum depression Am J Psychiatry 2000 157 924-930 10.1176/appi.ajp.157.6.924 10831472
53. Osterlund MK Overstreet DH Hurd YL The flinders sensitive line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17beta-estradiol Brain Res Mol Brain Res 1999 74 158-166 10.1016/S0169-328X(99)00274-0 10640686
54. Morrison MF Kallan MJ Ten HT Katz I Tweedy K Battistini M Lack of efficacy of estradiol for depression in postmenopausal women: A randomized, controlled trial Biol Psychiatry 2004 55 406-412 10.1016/ j.biopsych.2003.08.011 14960294
55. Miller KJ The other side of estrogen replacement therapy: Outcome study results of mood improvement in estrogen users and nonusers Curr Psychiatry Rep 2003 5 439-444 14609498
56. Klaiber EL Broverman DM Vogel W Kobayashi Y Estrogen therapy for severe persistent depressions in women Arch Gen Psychiatry 1979 36 550-554 219802
57. Lipsett MB Estrogen use and cancer risk J Am Med Assoc 1977 237 1112-1115 10.1001/jama.237.11.1112 12277690
58. Gorski J Wendell D Gregg D Chun TY Estrogens and the genetic control of tumor growth. [Review] [23 refs] Progress in Clinical & Biological Research 1997 396 233-243
59. File SE Heard JE Rymer J Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants Psychopharmacology (Berl) 2002 161 107-112 10.1007/ s00213-002-1032-3 11967638
60. Maki PM A systematic review of clinical trials of hormone therapy on cognitive function: Effects of age at initiation and progestin use Ann N Y Acad Sci 2005 1052 182-197 10.1196/annals.1347.012 16024761
61. Simpkins JW Green PS Gridley KE Singh M de Fiebre NC Rajakumar G Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease Am J Med 1997 103 19S-25S 10.1016/S0002-9343(97)00260-X 9344403
62. Haynes LE Lendon CL Barber DJ Mitchell IJ 17 Beta-oestradiol attenuates dexamethasone-induced lethal and sublethal neuronal damage in the striatum and hippocampus Neuroscience 2003 120 799-806 10.1016/ S0306-4522(03)00167-2 12895519
63. vom Saal FS Hughes C An extensive new literature concenring low-dose effects of bisphenol A shows the need for a new risk assessment Environ Health Perspect 2005 113 926-933 1280330 16079060
64. Blakely RD Bauman AL Biogenic amine transporters: Regulation in flux Curr Opin Neurobiol 2000 10 328-336 10.1016/S0959-4388(00)00088-X 10851182
65. Buckley KM Melikian HE Provoda CJ Waring MT Regulation of neuronal function by protein trafficking: A role for the endosomal pathway J Physiol 2000 525 Pt 1 11-19 10.1111/j.1469-7793.2000.t01-2-00011.x 10811720
66. Loder MK Melikian HE The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines J Biol Chem 2003 278 22168-22174 10.1074/jbc.M301845200 12682063
67. Melikian HE Neurotransmitter transporter trafficking: Endocytosis, recycling, and regulation Pharmacol Ther 2004 104 17-27 10.1016/ j.pharmthera.2004.07.006 15500906
68. Gulley JM Doolen S Zahniser NR Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo J Neurochem 2002 83 400-411 10.1046/ j.1471-4159.2002.01133.x 12423250
69. Watson CS Signaling themes shared between peptide and steroid hormones at the plasma membrane Sci STKE 1999 1999 E1
70. Torres GE Gainetdinov RR Caron MG Plasma membrane monoamine transporters: Structure, regulation and function Nat Rev Neurosci 2003 4 13-25 10.1038/nrn1008 12511858
71. Zivadinovic D Gametchu B Watson CS Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses Breast Cancer Res 2005 7 R101-R112 1064104 15642158 10.1186/ bcr958
72. Gametchu B Watson CS Wu S Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients FASEB J 1993 7 1283-1293 8405814
73. Gametchu B Watson CS Correlation of membrane glucocorticoid receptor levels with glucocorticoid-induced apoptotic competence using mutant leukemic and lymphoma cells lines Journal of Cellular Biochemistry 2002 87 133-146 10.1002/jcb.10288 12244567
74. Marquez DC Pietras RJ Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells Oncogene 2001 20 5420-5430 10.1038/sj.onc.1204729 11571639
75. Song RX Barnes CJ Zhang Z Bao Y Kumar R Santen RJ The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane Proc Natl Acad Sci U S A 2004 101 2076-2081 357054 14764897 10.1073/pnas.0308334100
76. Funakoshi T Yanai A Shinoda K Kawano MM Mizukami Y G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane Biochem Biophys Res Commun 2006 346 904-910 10.1016/j.bbrc.2006.05.191 16780796
77. Melikian HE Buckley KM Membrane trafficking regulates the activity of the human dopamine transporter J Neurosci 1999 19 7699-7710 10479674
78. Mizuta I Ohta M Ohta K Nishimura M Mizuta E Hayashi K Kuno S Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes Biochem Biophys Res Commun 2000 279 751-755 10.1006/bbrc.2000.4037 11162424